MHRA statement on Allergan

0
45

Statement from the Medicines and Healthcare products Regulatory Agency on Allergan suspending sales of textured breast implants and tissue expanders in Europe.

We are aware Allergan have stopped selling textured breast implants and tissue expanders and intend to withdraw remaining supply in European markets.

There is currently no evidence of an increased risk to patients and there is no need for people who have Allergan breast implants to get them removed or have any additional clinical follow-up.

We are monitoring the situation closely and will provide updates as necessary.

If you have any questions about your implants, please speak to your implanting surgeon or clinic.